catalent.com (CTLT) Company Gross Revenue

Demand for innovative drug delivery systems makes Catalent, Inc. (CTLT) a key partner for biotech startups. The GURU.Markets service features a line chart illustrating the company's revenue dynamics, where 4.42 is the current value of the indicator. Network resilience is ensured by factory diversification, while the unrivaled capacity utilization for syringe filling guarantees maximum cash flow.

Revenue and Sales Volume: Catalent Pharma Solutions (CTLT) for 07/04/2022 - 01/04/2025

Comprehensive metric breakdowns and analytics for Catalent (CTLT)

- share price and consensus valuation forecast:

Price Catalent, Inc|CTLT - Price Target Chart

- market capitalization details:

Market Capitalization Catalent, Inc.|CTLT - Enterprise Value

- book capitalization data:

Accounting Value per Share Catalent|CTLT - Book Capitalization|Market Capitalization to Book Value Ratio catalent.com|CTLT - Cumulative Company Assets

- debt and solvency information:

- company profitability and valuation multiples indicators:

CTLT - Net Income|Future Net Profit Catalent, Inc.|CTLT - Price to Earnings Ratio|Future Price to Earnings Multiple catalent.com|CTLT - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Catalent, Inc.|CTLT - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Catalent|CTLT - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months catalent.com|CTLT - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year Catalent, Inc.

- company sales and revenue statistics:

CTLT - Revenue and Sales Volume|Company Future Sales Volume Catalent, Inc|CTLT - Market Cap to Revenue|Price to Expected Revenue Ratio Catalent, Inc.

Comprehensive company analysis:Catalent, Inc

Sales for Catalent, Inc. reflect the daily cash flow from core operations, allowing for an assessment of the business's operational resilience and the justification of its market value. By analyzing the company's product sales, an investor can see the impact of high switching costs for contractors within customers' R&D processes, which guarantees revenue stability for Catalent, Inc. and minimizes the risks of a sharp decline in fundamental indicators.

Key competitors